Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βCombination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapiesβ.
Ayush Peddireddi, Subodh Bhatta, Ying Huang, Evandro D. Bezerra, Jonathan E. Brammer +6 more